First experience with BAK-free travoprost 0.004% in topical glaucoma medication
Ahmed Salah Gado, Tamer Ahmed MackyDepartment of Ophthalmology, Cairo University, Cairo, EgyptObjectives: Benzalkonium chloride (BAK)-free travoprost 0.004% (Travatan Z®, Alcon Laboratories, Inc, Fort Worth, TX) is a new formulation that was developed with the aim of creating a formulati...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-12-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/first-experience-with-bak-free-travoprost-0004-in-topical-glaucoma-med-a8857 |